News

PolyPid's Innovative Presentation at Key Biopharma Conference

PolyPid's Innovative Presentation at Key Biopharma Conference

PolyPid's Participation in a Notable Conference

PolyPid Ltd., a leading biopharmaceutical company, is committed to enhancing surgical outcomes with its innovative approaches. Recently, the company announced its participation in a vital conference, showcasing its advancements in the field.

Details of the Presentation

Dalit Hazan, the Deputy CEO and Executive Vice President of Research, Development, Clinical, and Regulatory Affairs, will represent the company. The presentation is scheduled for a prime slot on September 7 during the highly anticipated Session 1, focused on 'Advances in Targeted and Controlled Drug Delivery.'

Significance of the Presentation

During her talk, Hazan will unveil the topic titled 'Novel Local Prolonged Drug Delivery: From Platform Idea to a Successful Phase III Trial'. This presentation aims to provide insights into how PolyPid’s unique methods are changing the landscape of drug delivery in surgical environments.

About PolyPid Ltd.

Founded with the goal of improving surgical outcomes, PolyPid Ltd. leverages its proprietary PLEX technology, which combines Polymer-Lipid Encapsulation technology with Active Pharmaceutical Ingredients (APIs). This cutting-edge approach enables healthcare professionals to administer therapeutics that release drugs at tailored rates over extended periods, addressing significant clinical needs.

Innovative Pipeline

PolyPid is progressing towards the submission of a New Drug Application for D-PLEX???, its lead product candidate aimed at preventing colorectal surgical site infections. Strong results from Phase III trials have set the stage for this exciting next step in 2026. Additionally, the company's robust pipeline spans various therapeutic areas, including oncology, obesity, and diabetes.

Meeting Key Stakeholders

Attending this conference not only signifies PolyPid's dedication to innovation but also provides an opportunity to engage with leading experts, researchers, and investors in the biopharma space. Such interactions can further enhance PolyPid’s strategic partnerships and educational outreach.

Company's Future Requests

Looking ahead, the company aims to explore further advancements in localized drug administration, which can significantly impact patient care. Dialogues established at these conferences could lead to collaborative projects that align with PolyPid's mission.

Company Contact Information

For more information about PolyPid, contact:
Ori Warshavsky
908-858-5995
IR@Polypid.com

Frequently Asked Questions

What is PolyPid Ltd. known for?

PolyPid Ltd. specializes in surgical therapeutics, focusing on local, prolonged drug delivery systems to improve surgical outcomes.

Who will present at the conference?

Dalit Hazan, Deputy CEO and EVP, will deliver a presentation on innovative drug delivery methods.

What technology does PolyPid use?

The company employs PLEX technology, integrating Polymer-Lipid Encapsulation with Active Pharmaceutical Ingredients for optimized drug delivery.

What are the future prospects for PolyPid?

PolyPid is set to submit a New Drug Application for its lead product, aiming for significant impact in preventing surgical site infections.

How can I contact PolyPid?

Interested parties can reach out via email at IR@Polypid.com for more inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 78

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 132

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 227

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
OlloBot's Emotional AI Robots Connect Beyond Tasks

Updated Category News Views 20

OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 142

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 183

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
Race for Life Rescue Logs 200 Flights for Shelter Pets

Updated Category News Views 127

Airborne Lifelines for Vulnerable Animals Ever picture an airplane filled with hope? Well, Race for Life Rescue isn't just carting metal through the sky; they're lifting spirits, one furry passenger at a time. Picture this: a nonprofit turning a clunky Beechcraft into a flying ark, whisking away 112 at-risk pets from Louisiana to fresh starts in the Northeast. And guess...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 91

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 208

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading

Top 5 Most Recently Viewed Articles

Hydrolix Achieves Recognition as Top Akamai Partner in North America

Updated Category News Views 230

Hydrolix's Recognition as a Leading Partner Hydrolix, renowned for revolutionizing log data economics, has received significant accolades for its contributions as a trusted partner in the tech landscape. The company’s streaming data lake platform has been recognized by Akamai as the North America Qualified Computing Partner of the Year. This prestigious award highlights...

Continue Reading
MicroStrategy Stock's Unexpected Decline Amid Positive Crypto News

Updated Category News Views 235

MicroStrategy Stock Dynamics MicroStrategy Inc Class A (MSTR), recognized for its substantial Bitcoin holdings, encountered a surprising decline in its stock price, falling by approximately 5% during a period of optimism in the cryptocurrency market. This downturn occurred despite recent significant legislative advancements that promise a brighter future for digital...

Continue Reading
Sepsis Diagnostics Market Growth: Innovations and Trends Ahead

Updated Category News Views 180

Sepsis Diagnostics Market Growth: Innovations and Trends Ahead The Sepsis Diagnostics market is witnessing a remarkable transformation fueled by an urgent need for enhanced awareness, prevention strategies, and groundbreaking technological innovations. This sector, expected to grow from USD 1.2 billion to an impressive USD 2.5 billion, reflects a compound annual growth...

Continue Reading
DocGo Stock Reaches New Heights Amid Surge in Healthcare Demand

Updated Category News Views 219

DocGo Stock Soars to New Heights In an impressive display of market confidence, DocGo (DCGO) stock has soared to a 52-week high, reaching $4.88, fueled by a remarkable 30% revenue growth year-over-year. This peak is reflective of a significant surge in investor interest, coinciding with an increasing demand for healthcare services and mobile health solutions. Over the...

Continue Reading
Earnings Insights for Essent Group: What Investors Should Know

Updated Category News Views 151

Essent Group's Upcoming Earnings Release Essent Group (NYSE: ESNT) is gearing up to share its quarterly earnings results, and investors are keenly anticipating the outcomes. The earnings report is expected to shed light on the company's financial health and future projections. Expected Earnings Performance Market analysts are forecasting that the Essent Group will report...

Continue Reading